Reversible graft dysfunction after cardiac transplantation.

被引:0
|
作者
Obadia, JF
Boissonnat, P
Bastien, O
Flamens, C
Martelloni, Y
Diab, C
Elfarra, M
Chassignolle, JF
Dureau, G
机构
[1] Hop Cardiol, Serv Chirurg Cardiothorac A, F-69003 Lyon, France
[2] Hop Cardiol, Serv Cardiol, F-69003 Lyon, France
[3] Hop Cardiol, Serv Anesthesie Reanimat, F-69003 Lyon, France
[4] Hop Cardiol, INSERM, U121, F-69003 Lyon, France
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The authors report 3 cases of major graft dysfunction after cardiac transplantation which recovered completely with biventricular mechanical assistance in 4 to 8 days. All three cases were primary biventricular graft failures in patients with normal preoperative pulmonary resistances. These early dysfunctions (with no signs of myocardial infarction on electro-or echocardiography and in the absence of abnormal increased peri-operative enzyme levels) associated with total functional recovery conforming to the definition of the phenomenon of myocardial stunning. These results argue in favour of aggressive management of primary graft dysfunction.
引用
收藏
页码:253 / 256
页数:4
相关论文
共 50 条
  • [41] Early Graft Dysfunction After Lung Transplantation
    Rosenheck, Justin
    Pietras, Colleen
    Cantu, Edward
    CURRENT PULMONOLOGY REPORTS, 2018, 7 (04) : 176 - 187
  • [42] Primary Graft Dysfunction After Heart Transplantation
    Chew H.C.
    Kumarasinghe G.
    Iyer A.
    Hicks M.
    Gao L.
    Doyle A.
    Jabbour A.
    Dhital K.
    Granger E.
    Jansz P.
    Hayward C.
    Keogh A.
    Kotlyar E.
    Spratt P.
    Macdonald P.
    Current Transplantation Reports, 2014, 1 (4) : 257 - 265
  • [43] Ironman and cardiac transplantation. High sporting exercise capacity before and after cardiac transplantation
    Brune, Stephan
    Kroidl, Rolf F.
    HERZ, 2006, 31 (06) : 586 - 592
  • [44] Graft vs. neuroblastoma effect after haploidentical transplantation.
    Lacitignola, L
    Tintori, V
    Bambi, F
    Mariani, MP
    Marchi, C
    Porfirio, B
    Gelli, MG
    Azzari, C
    Tamburini, A
    Tucci, F
    Lippi, A
    Bernini, G
    Lawrence, F
    BLOOD, 2003, 102 (11) : 476B - 476B
  • [45] Thioredoxin and glutaredoxin as markers of graft rejection after liver transplantation.
    Martínez-Galisteo, E
    Monrobel, A
    Muntané, J
    Padilla, CA
    Montero, JL
    Granados, MD
    De la Mata, M
    Bárcena, JA
    Miño, G
    HEPATOLOGY, 1998, 28 (04) : 354A - 354A
  • [46] THE IMPLICATION OF ALLOANTIBODIES ON GRAFT HISTOLOGY AFTER PEDIATRIC LIVER TRANSPLANTATION.
    Weaver, K.
    Bryan, C.
    Poola, A.
    Fioravanti, V.
    Sherman, A. K.
    Hendrickson, R. J.
    Andrews, W.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 22 - 22
  • [47] The Influence of Comorbidity On Graft and Patient Survival After Kidney Transplantation.
    Laging, M.
    Kal-van Gestel, J.
    van de Wetering, J.
    Ijzermans, J.
    Betjes, M.
    Weimar, W.
    Roodnat, J.
    TRANSPLANTATION, 2014, 98 : 119 - 120
  • [48] MRP2 Expression in Human Hepatocytes Can Be a Marker of Predicting Graft Dysfunction after Liver Transplantation.
    Yi, Nam-Joon
    Kim, Juhyun
    Lee, Hae Won
    Lee, Kyoung-Bun
    You, Tae
    Suh, Suk-Won
    Park, Min-Su
    Choi, Young-Rok
    Kim, Hyeyoung
    Hong, Geun
    Lee, Kwang-Woong
    Jang, Ja-June
    Suh, Kyoung-Suk
    LIVER TRANSPLANTATION, 2013, 19 : S187 - S188
  • [49] Predictors For Better Graft Survival After Intestinal and Multivisceral Transplantation.
    Kumar, G.
    Mazariegos, G.
    Costa, G.
    Gupta, G.
    Soltys, K.
    Sindhi, R.
    Bond, G.
    Humar, A.
    Sogawa, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 215 - 215
  • [50] Oral budesonide in the prevention of graft rejection after liver transplantation.
    Deschenes, M
    Cantarovich, M
    Barkun, J
    Metrakos, P
    Alpert, E
    Tchervenkov, J
    HEPATOLOGY, 2000, 32 (04) : 598A - 598A